SEARCH

SEARCH BY CITATION

References

  • Antinori A., Arendt G., Becker J. T. et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69, 17891799.
  • Arnold W. P., Mittal C. K., Katsuki S. and Murad F. (1977) Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc. Natl Acad. Sci. USA 74, 32033207.
  • Bachani M., Sacktor N., McArthur J. C., Nath A. and Rumbaugh J. (2013) Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders. J. Neurovirol. 19, 8288.
  • Bain J., Plater L., Elliott M. et al. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297315.
  • Bock H. H. and Herz J. (2003) Reelin activates SRC family tyrosine kinases in neurons. Curr. Biol. 13, 1826.
  • Browning D. D., Mc Shane M., Marty C. and Ye R. D. (2001) Functional analysis of type 1alpha cGMP-dependent protein kinase using green fluorescent fusion proteins. J. Biol. Chem. 276, 1303913048.
  • Bu G. (2001) The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family. Int. Rev. Cytol. 209, 79116.
  • Butt E., Abel K., Krieger M., Palm D., Hoppe V., Hoppe J. and Walter U. (1994) cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J. Biol. Chem. 269, 1450914517.
  • Carey A. N., Sypek E. I., Singh H. D., Kaufman M. J. and McLaughlin J. P. (2012) Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behav. Brain Res. 229, 4856.
  • Chandra T., Maier W., Konig H. G., Hirzel K., Kogel D., Schuler T., Chandra A., Demirhan I. and Laube B. (2005) Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits. Neuroscience 134, 145153.
  • Chang H. C., Samaniego F., Nair B. C., Buonaguro L. and Ensoli B. (1997) HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 11, 14211431.
  • Choi Y. B., Tenneti L., Le D. A., Ortiz J., Bai G., Chen H. S. V. and Lipton S. A. (2000) Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat. Neurosci. 3, 1521.
  • Contestabile A. and Ciani E. (2004) Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation. Neurochem. Int. 45, 903914.
  • Crump F. T., Dillman K. S. and Craig A. M. (2001) cAMP-dependent protein kinase mediates activity-regulated synaptic targeting of NMDA receptors. J. Neurosci. 21, 50795088.
  • Cysique L. A., Maruff P. and Brew B. J. (2004) Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J. Neurovirol. 10, 350357.
  • Del Valle L., Croul S., Morgello S., Amini S., Rappaport J. and Khalili K. (2000) Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J. Neurovirol. 6, 221228.
  • Ellis R., Langford D. and Masliah E. (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat. Rev. Neurosci. 8, 3344.
  • Eugenin E. A., King J. E., Nath A., Calderon T. M., Zukin R. S., Bennett M. V. and Berman J. W. (2007) HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes. Proc. Natl Acad. Sci. USA 104, 34383443.
  • Fitting S., Ignatowska-Jankowska B. M., Bull C. et al. (2012) Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 tat transgenic mice. Biol. Psychiatry 73, 443453.
  • Furukawa K. and Mattson M. P. (1998) Secreted amyloid precursor protein alpha selectively suppresses N-methyl-D-aspartate currents in hippocampal neurons: involvement of cyclic GMP. Neuroscience 83, 429438.
  • Furukawa K., Smithswintosky V. L. and Mattson M. P. (1995) Evidence that actin depolymerization protects hippocampal neurons against excitotoxicity by stabilizing [ca2 + ](i). Exp. Neurol. 133, 153163.
  • Gallo E. F. and Iadecola C. (2011) Neuronal nitric oxide contributes to neuroplasticity-associated protein expression through cGMP, protein kinase G, and extracellular signal-regulated kinase. J. Neurosci. 31, 69476955.
  • Genis P., Jett M., Bernton E. W. et al. (1992) Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176, 17031718.
  • Groc L., Heine M., Cousins S. L., Stephenson F. A., Lounis B., Cognet L. and Choquet D. (2006) NMDA receptor surface mobility depends on NR2A-2B subunits. Proc. Natl Acad. Sci. USA 103, 1876918774.
  • Grynkiewicz G., Poenie M. and Tsien R. Y. (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 34403450.
  • Hargus N. J. and Thayer S. A. (2013) Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture. J. Neurosci. 33, 1790817920.
  • Haughey N. J., Nath A., Mattson M. P., Slevin J. T. and Geiger J. D. (2001) HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J. Neurochem. 78, 457467.
  • Heaton R. K., Marcotte T. D., Mindt M. R., Sadek J., Moore D. J., Bentley H., McCutchan J. A., Reicks C. and Grant I. (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J. Int. Neuropsychol. Soc. 10, 317331.
  • Heaton R. K., Clifford D. B., Franklin D. R., Jr et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75, 20872096.
  • Heaton R. K., Franklin D. R., Ellis R. J. et al. (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol. 17, 316.
  • Herz J. and Strickland D. K. (2001) LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108, 779784.
  • Hudson L., Liu J., Nath A., Jones M., Raghavan R., Narayan O., Male D. and Everall I. (2000) Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J. Neurovirol. 6, 145155.
  • Hui L., Chen X., Haughey N. J. and Geiger J. D. (2012) Role of endolysosomes in HIV-1 Tat-induced neurotoxicity. ASN Neuro 4, 243252.
  • Jaffrey S. R., Erdjument-Bromage H., Ferris C. D., Tempst P. and Snyder S. H. (2001) Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol. 3, 193197.
  • Jiang Z. G., Piggee C., Heyes M. P., Murphy C., Quearry B., Bauer M., Zheng J., Gendelman H. E. and Markey S. P. (2001) Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J. Neuroimmunol. 117, 97107.
  • Kaul M., Garden G. A. and Lipton S. A. (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988994.
  • Kim H. J., Martemyanov K. A. and Thayer S. A. (2008) Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death. J. Neurosci. 28, 1260412613.
  • Kim H. J., Shin A. H. and Thayer S. A. (2011) Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss. Mol. Pharmacol. 80, 357366.
  • King J. E., Eugenin E. A., Buckner C. M. and Berman J. W. (2006) HIV tat and neurotoxicity. Microbes Infect. 8, 13471357.
  • King J. E., Eugenin E. A., Hazleton J. E., Morgello S. and Berman J. W. (2010) Mechanisms of HIV-tat-induced phosphorylation of N-methyl-D-aspartate receptor subunit 2A in human primary neurons: implications for neuroAIDS pathogenesis. Am. J. Pathol. 176, 28192830.
  • Kohr G. and Seeburg P. H. (1996) Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family. J. Physiol. 492(Pt 2), 445452.
  • Kuo J. F. and Greengard P. (1972) An assay method for cyclic AMP and cyclic GMP based upon their abilities to activate cyclic AMP-dependent and cyclic GMP-dependent protein kinases. Adv. Cyclic. Nucleotide Res. 2, 4150.
  • Lavezzari G., McCallum J., Lee R. and Roche K. W. (2003) Differential binding of the AP-2 adaptor complex and PSD-95 to the C-terminus of the NMDA receptor subunit NR2B regulates surface expression. Neuropharmacology 45, 729737.
  • Lavezzari G., McCallum J., Dewey C. M. and Roche K. W. (2004) Subunit-specific regulation of NMDA receptor endocytosis. J. Neurosci. 24, 63836391.
  • Lei S. Z., Pan Z. H., Aggarwal S. K., Chen H. S., Hartman J., Sucher N. J. and Lipton S. A. (1992) Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8, 10871099.
  • Lei S., Czerwinska E., Czerwinski W., Walsh M. P. and MacDonald J. F. (2001) Regulation of NMDA receptor activity by F-actin and myosin light chain kinase. J. Neurosci. 21, 84648472.
  • Li W., Huang Y., Reid R. et al. (2008) NMDA receptor activation by HIV-Tat protein is clade dependent. J. Neurosci. 28, 1219012198.
  • Li W., Li G., Steiner J. and Nath A. (2009) Role of Tat Protein in HIV Neuropathogenesis. Neurotox. Res. 16, 205220.
  • Li Y., Krogh K. A. and Thayer S. A. (2012) Epileptic stimulus increases Homer 1a expression to modulate endocannabinoid signaling in cultured hippocampal neurons. Neuropharmacology 63, 11401149.
  • Li Y., Popko J., Krogh K. A. and Thayer S. A. (2013) Epileptiform stimulus increases Homer 1a expression to modulate synapse number and activity in hippocampal cultures. J. Neurophysiol. 109, 14941504.
  • Lipton S. A. and Stamler J. S. (1994) Actions of redox-related congeners of nitric oxide at the NMDA receptor. Neuropharmacology 33, 12291233.
  • Lipton S. A., Choi Y. B., Pan Z. H., Lei S. Z., Chen H. S., Sucher N. J., Loscalzo J., Singel D. J. and Stamler J. S. (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626632.
  • Liu Y., Jones M., Hingtgen C. M., Bu G., Laribee N., Tanzi R. E., Moir R. D., Nath A. and He J. J. (2000) Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat. Med. 6, 13801387.
  • Liu T., Jiang C. Y., Fujita T., Luo S. W. and Kumamoto E. (2013) Enhancement by interleukin-1beta of AMPA and NMDA receptor-mediated currents in adult rat spinal superficial dorsal horn neurons. Mol. Pain 9, 16.
  • Maier W., Bednorz M., Meister S., Roebroek A., Weggen S., Schmitt U. and Pietrzik C. U. (2013) LRP1 is critical for the surface distribution and internalization of the NR2B NMDA receptor subtype. Mol. Neurodegener. 8, 25.
  • Malhotra A. K., Pinals D. A., Weingartner H., Sirocco K., Missar C. D., Pickar D. and Breier A. (1996) NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14, 301307.
  • Manzoni O., Prezeau L., Marin P., Deshager S., Bockaert J. and Fagni L. (1992) Nitric oxide-induced blockade of NMDA receptors. Neuron 8, 653662.
  • Nath A. (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J. Infect. Dis. 186(Suppl 2), S193S198.
  • Newcomer J. W. and Krystal J. H. (2001) NMDA receptor regulation of memory and behavior in humans. Hippocampus 11, 529542.
  • Nong Y., Huang Y. Q., Ju W., Kalia L. V., Ahmadian G., Wang Y. T. and Salter M. W. (2003) Glycine binding primes NMDA receptor internalization. Nature 422, 302307.
  • Passiatore G., Rom S., Eletto D. and Peruzzi F. (2009) HIV-1 Tat C-terminus is cleaved by calpain 1: implication for Tat-mediated neurotoxicity. Biochim. Biophys. Acta 1793, 378387.
  • Potter M. C., Figuera-Losada M., Rojas C. and Slusher B. S. (2013) Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders. J. Neuroimmune Pharmacol. 8, 594607.
  • Qiu Z., Strickland D. K., Hyman B. T. and Rebeck G. W. (2002) alpha 2-Macroglobulin exposure reduces calcium responses to N-methyl-D- aspartate via low density lipoprotein receptor-related protein in cultured hippocampal neurons. J. Biol. Chem. 277, 1445814466.
  • Qiu Z., Crutcher K. A., Hyman B. T. and Rebeck G. W. (2003) ApoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience 122, 291303.
  • Rosenmund C. and Westbrook G. L. (1993) Calcium-induced actin depolymerization reduces NMDA channel activity. Neuron 10, 805814.
  • Rossi S., Studer V., Moscatelli A. et al. (2013) Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis. PLoS ONE 8, e67357.
  • Salter M. W. and Kalia L. V. (2004) Src kinases: a hub for NMDA receptor regulation. Nat. Rev. Neurosci. 5, 317328.
  • She K., Ferreira J. S., Carvalho A. L. and Craig A. M. (2012) Glutamate binding to the GluN2B subunit controls surface trafficking of N-methyl-D-aspartate (NMDA) receptors. J. Biol. Chem. 287, 2743227445.
  • Shen G. and Tietz E. I. (2011) Down-regulation of synaptic GluN2B subunit-containing N-methyl-D-aspartate receptors: a physiological brake on CA1 neuron alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid hyperexcitability during benzodiazepine withdrawal. J. Pharmacol. Exp. Ther. 336, 265273.
  • Shi Y., Mantuano E., Inoue G., Campana W. M. and Gonias S. L. (2009) Ligand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway. Sci. Signal. 2, ra18.
  • Shin A. H., Kim H. J. and Thayer S. A. (2012) Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat. Br. J. Pharmacol. 166, 10021017.
  • Snyder E. M., Nong Y., Almeida C. G. et al. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8, 10511058.
  • Song L., Nath A., Geiger J. D., Moore A. and Hochman S. (2003) Human immunodeficiency virus type 1 Tat protein directly activates neuronal N -methyl- D -aspartate receptors at an allosteric zinc-sensitive site. J. Neurovirol. 9, 399403.
  • Spalloni A., Nutini M. and Longone P. (2013) Role of the N-methyl-d-aspartate receptors complex in amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1832, 312322.
  • Steinaa L., Sorensen A. M., Nielsen J. O. and Hansen J. E. (1994) Antibody to HIV-1 Tat protein inhibits the replication of virus in culture. Arch. Virol. 139, 263271.
  • Sunico C. R., Gonzalez-Forero D., Dominguez G., Garcia-Verdugo J. M. and Moreno-Lopez B. (2010) Nitric Oxide Induces Pathological Synapse Loss by a Protein Kinase G-, Rho Kinase-Dependent Mechanism Preceded by Myosin Light Chain Phosphorylation. J. Neurosci. 30, 973984.
  • Tang Y. P., Shimizu E., Dube G. R., Rampon C., Kerchner G. A., Zhuo M., Liu G. and Tsien J. Z. (1999) Genetic enhancement of learning and memory in mice. Nature 401, 6369.
  • Tovar K. R. and Westbrook G. L. (1999) The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J. Neurosci. 19, 41804188.
  • Tozzi V., Balestra P., Serraino D. et al. (2005) Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res. Hum. Retroviruses 21, 706713.
  • Viviani B., Bartesaghi S., Gardoni F. et al. (2003) Interleukin-1b enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 23, 86928700.
  • Wang X. and Robinson P. J. (1997) Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 68, 443456.
  • Wang Y. T. and Salter M. W. (1994) Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature 369, 233235.
  • Watkins B. A., Dorn H. H., Kelly W. B., Armstrong R. C., Potts B. J., Michaels R., Kufta C. V. and Dubois-Dalcq M. (1990) Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 249, 549553.
  • Wiley C. A., Baldwin M. and Achim C. L. (1996) Expression of regulatory and structural mRNA in the central nervous system. AIDS 10, 943947.
  • Williams K. (1993) Ifenprodil discriminates subtypes of the N-Methyl-D-aspartate receptor - selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44, 851859.
  • Wu P. J., Coultrap S. J., Browning M. D. and Proctor W. R. (2011) Functional adaptation of the N-methyl-D-aspartate receptor to inhibition by ethanol is modulated by striatal-enriched protein tyrosine phosphatase and p38 mitogen-activated protein kinase. Mol. Pharm. 80, 529537.
  • Xiao H., Neuveut C., Lee H., Benkirane M., Rich E. A., Murphy P. M. and Jeang K.-T. (2000) Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc. Natl Acad. Sci. USA 97, 1146611471.
  • Young A. B., Greenamyre J. T., Hollingsworth Z., Albin R., D'Amato C., Shoulson I. and Penney J. B. (1988) NMDA receptor losses in putamen from patients with Huntington's disease. Science 241, 981983.